Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1993 Jul;67(7):3861–3867. doi: 10.1128/jvi.67.7.3861-3867.1993

Polygenic control of neuroinvasiveness in California serogroup bunyaviruses.

C Griot 1, A Pekosz 1, D Lukac 1, S S Scherer 1, K Stillmock 1, D Schmeidler 1, M J Endres 1, F Gonzalez-Scarano 1, N Nathanson 1
PMCID: PMC237751  PMID: 8510208

Abstract

The pathogenesis of the California serogroup bunyaviruses includes both extraneural and intraneural replicative phases that can be separated experimentally. The present study dissects the viral genetic determinants of extraneural replication. We have previously described two attenuated reassortant clones of California serogroup bunyaviruses which exhibit reduced neuroinvasiveness after subcutaneous inoculation into suckling mice. Clone B1-1a bears an attenuated middle RNA segment (neuroinvasiveness phenotype v alpha v), and clone B.5 bears an attenuated large RNA segment (neuroinvasiveness phenotype alpha vv). We prepared reassortant viruses between these two strains and found that the two attenuated gene segments acted independently and additively, since reassortants bearing two attenuated RNA segments were more attenuated than the parental clones. Reassortants bearing no attenuated RNA segments were much more neuroinvasive than either parental clone, indicating that a neuroinvasive strain can be derived from two attenuated clones. Pathogenesis studies demonstrated that after injection of 10(3) PFU, the attenuated reassortant clones did not replicate in peripheral tissue, failed to reach the brain, and did not cause disease. At a dose of 10(6) PFU, attenuated clones failed to replicate to a significant level in peripheral tissue and produced only a minimal passive plasma viremia during the first 24 h but nevertheless reached high titers in the brain and killed mice. Because of this result, we investigated the possibility that neuroinvasion occurs via retrograde axonal transport, by determining whether sciatic nerve sectioning could protect against virus infection after hind leg footpad inoculation. We found that nerve sectioning had no effect on lethality, ruling out this mode of entry and suggesting that passive viremia is likely to be sufficient for invasion of the central nervous system.

Full text

PDF
3861

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaty B. J., Calisher C. H. Bunyaviridae--natural history. Curr Top Microbiol Immunol. 1991;169:27–78. [PubMed] [Google Scholar]
  2. Beaty B. J., Thompson W. H. Delineation of La Crosse virus in developmental stages of transovarially infected Aedes triseriatus. Am J Trop Med Hyg. 1976 May;25(3):505–512. doi: 10.4269/ajtmh.1976.25.505. [DOI] [PubMed] [Google Scholar]
  3. Bishop D. H. Genetic potential of bunyaviruses. Curr Top Microbiol Immunol. 1979;86:1–33. doi: 10.1007/978-3-642-67341-2_1. [DOI] [PubMed] [Google Scholar]
  4. Cash P., Vezza A. C., Gentsch J. R., Bishop D. H. Genome complexities of the three mRNA species of snowshoe hare bunyavirus and in vitro translation of S mRNA to viral N polypeptide. J Virol. 1979 Sep;31(3):685–694. doi: 10.1128/jvi.31.3.685-694.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Day S. P., Lausch R. N., Oakes J. E. Evidence that the gene for herpes simplex virus type 1 DNA polymerase accounts for the capacity of an intertypic recombinant to spread from eye to central nervous system. Virology. 1988 Mar;163(1):166–173. doi: 10.1016/0042-6822(88)90243-7. [DOI] [PubMed] [Google Scholar]
  6. Elliott R. M. Nucleotide sequence analysis of the large (L) genomic RNA segment of Bunyamwera virus, the prototype of the family Bunyaviridae. Virology. 1989 Dec;173(2):426–436. doi: 10.1016/0042-6822(89)90555-2. [DOI] [PubMed] [Google Scholar]
  7. Endres M. J., Griot C., Gonzalez-Scarano F., Nathanson N. Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment. J Virol. 1991 Oct;65(10):5465–5470. doi: 10.1128/jvi.65.10.5465-5470.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Endres M. J., Jacoby D. R., Janssen R. S., Gonzalez-Scarano F., Nathanson N. The large viral RNA segment of California serogroup bunyaviruses encodes the large viral protein. J Gen Virol. 1989 Jan;70(Pt 1):223–228. doi: 10.1099/0022-1317-70-1-223. [DOI] [PubMed] [Google Scholar]
  9. Endres M. J., Valsamakis A., Gonzalez-Scarano F., Nathanson N. Neuroattenuated bunyavirus variant: derivation, characterization, and revertant clones. J Virol. 1990 May;64(5):1927–1933. doi: 10.1128/jvi.64.5.1927-1933.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fazakerley J. K., Gonzalez-Scarano F., Strickler J., Dietzschold B., Karush F., Nathanson N. Organization of the middle RNA segment of snowshoe hare Bunyavirus. Virology. 1988 Dec;167(2):422–432. [PubMed] [Google Scholar]
  11. Fuller F., Bhown A. S., Bishop D. H. Bunyavirus nucleoprotein, N, and a non-structural protein, NSS, are coded by overlapping reading frames in the S RNA. J Gen Virol. 1983 Aug;64(Pt 8):1705–1714. doi: 10.1099/0022-1317-64-8-1705. [DOI] [PubMed] [Google Scholar]
  12. Gentsch J. R., Bishop D. H. Small viral RNA segment of bunyaviruses codes for viral nucleocapsid protein. J Virol. 1978 Oct;28(1):417–419. doi: 10.1128/jvi.28.1.417-419.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gonzalez-Scarano F., Beaty B., Sundin D., Janssen R., Endres M. J., Nathanson N. Genetic determinants of the virulence and infectivity of La Crosse virus. Microb Pathog. 1988 Jan;4(1):1–7. doi: 10.1016/0882-4010(88)90041-1. [DOI] [PubMed] [Google Scholar]
  14. Gonzalez-Scarano F., Endres M. J., Nathanson N. Bunyaviridae: Pathogenesis. Curr Top Microbiol Immunol. 1991;169:217–249. [PubMed] [Google Scholar]
  15. Gonzalez-Scarano F., Jacoby D., Griot C., Nathanson N. Genetics, infectivity and virulence of California serogroup viruses. Virus Res. 1992 Jul;24(2):123–135. doi: 10.1016/0168-1702(92)90001-p. [DOI] [PubMed] [Google Scholar]
  16. Gonzalez-Scarano F., Shope R. E., Calisher C. E., Nathanson N. Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses. Virology. 1982 Jul 15;120(1):42–53. doi: 10.1016/0042-6822(82)90005-8. [DOI] [PubMed] [Google Scholar]
  17. HAMMON W. M., REEVES W. C. California encephalitis virus, a newly described agent. Calif Med. 1952 Nov;77(5):303–309. [PMC free article] [PubMed] [Google Scholar]
  18. Jacoby D. R., Cooke C., Prabakaran I., Boland J., Nathanson N., Gonzalez-Scarano F. Expression of the La Crosse M segment proteins in a recombinant vaccinia expression system mediates pH-dependent cellular fusion. Virology. 1993 Apr;193(2):993–996. doi: 10.1006/viro.1993.1213. [DOI] [PubMed] [Google Scholar]
  19. Janssen R., Gonzalez-Scarano F., Nathanson N. Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus. Lab Invest. 1984 Apr;50(4):447–455. [PubMed] [Google Scholar]
  20. Kappus K. D., Monath T. P., Kaminski R. M., Calisher C. H. Reported encephalitis associated with California serogroup virus infections in the United States, 1963-1981. Prog Clin Biol Res. 1983;123:31–41. [PubMed] [Google Scholar]
  21. Morrison L. A., Sidman R. L., Fields B. N. Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3852–3856. doi: 10.1073/pnas.88.9.3852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Málková D. Virulence of Tahyna virus in mice and its relation to thermosensitivity and character of plaque population markers. Acta Virol. 1971 Nov;15(6):473–478. [PubMed] [Google Scholar]
  23. Ren R., Racaniello V. R. Poliovirus spreads from muscle to the central nervous system by neural pathways. J Infect Dis. 1992 Oct;166(4):747–752. doi: 10.1093/infdis/166.4.747. [DOI] [PubMed] [Google Scholar]
  24. Shope R. E., Rozhon E. J., Bishop D. H. Role of the middle-sized bunyavirus RNA segment in mouse virulence. Virology. 1981 Oct 15;114(1):273–276. doi: 10.1016/0042-6822(81)90276-2. [DOI] [PubMed] [Google Scholar]
  25. Snyder M. H., Betts R. F., DeBorde D., Tierney E. L., Clements M. L., Herrington D., Sears S. D., Dolin R., Maassab H. F., Murphy B. R. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J Virol. 1988 Feb;62(2):488–495. doi: 10.1128/jvi.62.2.488-495.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Snyder M. H., Buckler-White A. J., London W. T., Tierney E. L., Murphy B. R. The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avian-human influenza A/Pintail/79 reassortant viruses for monkeys. J Virol. 1987 Sep;61(9):2857–2863. doi: 10.1128/jvi.61.9.2857-2863.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tsai T. F. Arboviral infections in the United States. Infect Dis Clin North Am. 1991 Mar;5(1):73–102. [PubMed] [Google Scholar]
  28. Tyler K. L., McPhee D. A., Fields B. N. Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science. 1986 Aug 15;233(4765):770–774. doi: 10.1126/science.3016895. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES